Latest News about REGN
Recent news which mentions REGN
Competitor Analysis: Evaluating Regeneron Pharmaceuticals And Competitors In Biotechnology Industry
September 11, 2024
From Benzinga
Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease
September 11, 2024
From Benzinga
Prediction: These 2 Companies Will Split Their Stocks by 2027
September 11, 2024
From Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today
September 10, 2024
From Benzinga
Beyond The Numbers: 20 Analysts Discuss Regeneron Pharmaceuticals Stock
September 09, 2024
Tickers
REGN
From Benzinga
Prediction: These 2 Cathie Wood Stocks Could Crush the Market Through 2030
September 05, 2024
From Motley Fool
From Benzinga
What Analysts Are Saying About Regeneron Pharmaceuticals Stock
August 23, 2024
Tickers
REGN
From Benzinga
From Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $130 Thousand Today
August 20, 2024
From Benzinga
7 Stocks That Usually Benefit From a Recession
August 13, 2024
From InvestorPlace
Insights Into Regeneron Pharmaceuticals's Performance Versus Peers In Biotechnology Sector
August 13, 2024
From Benzinga
From InvestorPlace
From Benzinga
3 Biotech Stocks With Promising Drug Pipelines: August 2024
August 08, 2024
From InvestorPlace
From InvestorPlace
Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs
August 01, 2024
From Benzinga
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
August 01, 2024
From Benzinga
From Benzinga
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
July 30, 2024
From Benzinga
From Benzinga
From Motley Fool
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
July 25, 2024
From Benzinga
MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients
July 23, 2024
From Benzinga
From Benzinga
Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
July 18, 2024
From Benzinga
3 Standout Stocks to Buy for the Next Bull Market
July 18, 2024
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
